Owner Bristol-Myers Squibb Company

Inventors Herpin, Timothy F.; Chen, Sean; Cheng, Peter T. W.; Ding, Charles Z.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003248861

PCT Number PCT/US03/21331

PCT Pub. Number WO2004/004655

Priority 60/394,553 09.07.02 US

Filing date 8 July 2003

Wipo publication date 23 January 2004

Acceptance publication date 22 January 2009

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/42 (2006.01) - Oxazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/50 (2006.01) - Pyridazines

A61K 31/52 (2006.01)

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms